Compare funds
Pick up to 10 funds. Compare funds from the same category for a fair reading.
Growth of ₹10,000
Basics
| ANGEL ONE NIFTY TOTAL MARKET ETF | Nippon India Nifty Pharma ETF | |
|---|---|---|
| Category | Equity ETFs | Equity ETFs |
| Plan | Direct | Direct |
| Fund house | Angel One | Nippon India |
| NAV | ₹12.2935 | ₹29.1863 |
| NAV date | 20 Nov 2026 | 20 Nov 2026 |
| History | 1.7 years | 5.4 years |
| Expense ratio | 0.3% | 0.2% |
| Stars | Not rated | Not rated |
| Growth Score | — | — |
Returns
| ANGEL ONE NIFTY TOTAL MARKET ETF | Nippon India Nifty Pharma ETF | |
|---|---|---|
| 1 month | +8.90% | +10.82% |
| 3 months | +2.79% | +7.43% |
| 6 months | +7.36% | +14.54% |
| YTD | +1.96% | +25.40% |
| 1 year | +1.37% | +25.57% |
| 3 years (CAGR) | — | +22.02% |
| 5 years (CAGR) | — | +16.60% |
| 10 years (CAGR) | — | — |
| Since launch | +11.56% | +14.02% |
Risk
| ANGEL ONE NIFTY TOTAL MARKET ETF | Nippon India Nifty Pharma ETF | |
|---|---|---|
| Volatility | — | 15.0% |
| Downside volatility | — | 9.0% |
| Sharpe | — | 1.04 |
| Sortino | — | 1.72 |
| Calmar | — | 1.33 |
| Return / risk | — | 1.47 |
| Deepest fall | −14.82% | −20.98% |
| Days to recover | 226 | 136 |
| Below its high | +0.00% | −1.75% |
Against benchmark
| ANGEL ONE NIFTY TOTAL MARKET ETF | Nippon India Nifty Pharma ETF | |
|---|---|---|
| Alpha | — | +0.00% |
| Beta | — | 1.00 |
| R² | — | 100.0% |
| Up capture | — | 100.0% |
| Down capture | — | 100.0% |
| Tracking error | — | 0.0% |
| Information ratio | — | — |
| Treynor | — | 0.14 |
Consistency
| ANGEL ONE NIFTY TOTAL MARKET ETF | Nippon India Nifty Pharma ETF | |
|---|---|---|
| Best 1-year | +12.36% | +65.21% |
| Middle 1-year | +0.70% | +13.46% |
| Worst 1-year | −8.79% | −15.30% |
| 1-year periods with a loss | 38.6% | 25.8% |
| Middle 3-year | — | +20.51% |
| Positive months | — | 61.1% |
| Best day | +3.95% | +3.64% |
| Worst day | −3.40% | −4.03% |
| Worst 5% day | −1.42% | −1.62% |
| Positive days | 52.8% | 54.4% |
| NAVs a year | 247 | 248 |
SIP of ₹10,000 a month
| ANGEL ONE NIFTY TOTAL MARKET ETF | Nippon India Nifty Pharma ETF | |
|---|---|---|
| 5-year XIRR | — | +20.60% |
| 5-year value | — | ₹10,11,738 |
| 3-year XIRR | — | +19.58% |
| 1-year XIRR | +9.69% | +34.31% |
Holdings overlap i
| ANGEL ONE NIFTY TOTAL MARKET ETF | Nippon India Nifty Pharma ETF | |
|---|---|---|
| ANGEL ONE NIFTY TOTAL MARKET ETF | — | 5% |
| Nippon India Nifty Pharma ETF | 5% | — |
Share of money in the same stocks, by weight. Above 50% means much of one fund repeats the other.
Held by all of them
| Stock | ANGEL ONE NIFTY TOTAL MARKET ETF | Nippon India Nifty Pharma ETF |
|---|---|---|
| Sun Pharmaceutical Industries Limited | 0.95% | 18.61% |
| Divi's Laboratories Limited | 0.63% | 12.28% |
| Laurus Labs Limited | 0.47% | 9.26% |
| Dr. Reddy's Laboratories Limited | 0.42% | 8.15% |
| Cipla Limited | 0.39% | 7.67% |
| Torrent Pharmaceuticals Limited | 0.34% | 6.71% |
| Lupin Limited | 0.25% | 4.83% |
| Aurobindo Pharma Limited | 0.23% | 4.59% |
| Glenmark Pharmaceuticals Limited | 0.17% | 3.42% |
| Zydus Lifesciences Limited | 0.16% | 3.05% |
| Alkem Laboratories Limited | 0.16% | 3.05% |
| Mankind Pharma Limited | 0.14% | 2.79% |
| IPCA Laboratories Limited | 0.13% | 2.65% |
| Gland Pharma Limited | 0.12% | 2.44% |
| Biocon Limited | 0.12% | 2.42% |
| Sai Life Sciences Limited | 0.11% | 2.13% |
| Ajanta Pharma Limited | 0.08% | 1.58% |
| Wockhardt Limited | 0.08% | 1.55% |
| Piramal Pharma Limited | 0.07% | 1.47% |
| Abbott India Limited | 0.07% | 1.32% |
Sectors and company size
| ANGEL ONE NIFTY TOTAL MARKET ETF | Nippon India Nifty Pharma ETF | |
|---|---|---|
| Large companies | 65.5% | 45.3% |
| Mid companies | 19.7% | 47.1% |
| Small companies | 14.7% | 7.6% |
| Top 10 holdings | 28.5% | 78.6% |
| Largest sector | Banks 19% | Pharmaceuticals & Biotechnology 100% |